Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
BeOne Medicines AG

BeOne Medicines AG (ONC) Stock Overview

Explore BeOne Medicines AG’s financial performance, market position, analyst ratings, and future outlook.

ONC●NASDAQ
HealthcareBiotechnology
$361.72
$0.87(0.24%)
U.S. Market is Open · 12:45

BeOne Medicines AG (ONC)

Meyka AI Score

Z

Key Financials

Market Cap39.2B
P/E Ratio4.82
EPS (TTM)$5.68
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$341.87
3 Months$351.90
1 Year Target$361.05

ONC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of BeOne Medicines AG (NASDAQ: ONC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, BeOne Medicines AG's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ONC on the NASDAQ shows an RSI of 58.20, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $361.05 for the NASDAQ listing.

Key metrics behind BeOne Medicines AG's NASDAQ-traded stock include a P/E ratio of 4.82 and a market capitalization of 39.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ONC on the NASDAQ.

Price Performance (NASDAQ: ONC)

1-Day Change
1.70%
5-Day Change
1.24%
1-Month Change
0.07%
3-Month Change
31.12%
6-Month Change
29.67%
Year-to-Date (YTD) Change
20.80%
1-Year Change
10.27%
3-Year Change
99.27%
5-Year Change
0.88%
All-Time (Max) Change
1195.90%

Contact Information

https://beonemedicines.com
345-949-4123
Aeschengraben 27, Basel, PA, 4051

Company Facts

120,000 Employees
IPO DateFeb 3, 2016
CountryCH
Actively Trading

Frequently Asked Questions